Concepedia

Ian P. Kirk

IP

Statistics

Publications

10

Citations

946

H-Index

10

Active since

1994

Affiliations

University of Cambridge(Current)

Loughborough University

AstraZeneca (United Kingdom)

Ian P. Kirk is an author at University of Cambridge specializing in medicine, pharmacology, and pharmacotherapy.

Top concepts

Publications per year

1994–2011

10

Publications

10

From ATP to AZD6140: The discovery of an orally active reversible P2Y12 receptor antagonist for the prevention of thrombosis

Brian Springthorpe, A. S. Bailey, Patrick Barton et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 233 citations · Full text

, , +8

Ticagrelor Inhibits Adenosine Uptake In Vitro and Enhances Adenosine-Mediated Hyperemia Responses in a Canine Model

J.J.J. van Giezen, James E. Sidaway, Philip Glaves et al. · Journal of Cardiovascular Pharmacology and Therapeutics · 2011 · 192 citations

Adenosine A<sub>2a</sub>Receptor‐Mediated Modulation of Striatal [<sup>3</sup>H]GABA and [<sup>3</sup>H]Acetylcholine Release

Ian P. Kirk, Peter J. Richardson · Journal of Neurochemistry · 1994 · 128 citations

Inhibition by KF17837 of adenosine A<sub>2A</sub> receptor‐mediated modulation of striatal GABA and ACh release

Masako Kurokawa, Ian P. Kirk, Karen A. Kirkpatrick et al. · British Journal of Pharmacology · 1994 · 109 citations · Full text

P2Y<sub>1</sub>‐receptors in human platelets which are pharmacologically distinct from P2Y<sub>ADP</sub>‐receptors

Malbinder Fagura, Ian Dainty, G D McKay et al. · British Journal of Pharmacology · 1998 · 100 citations · Full text

1–5 of 10